Musk Predicts “Banger Drugs Coming Out” from Eli Lilly
Yahoo Finance · Nov 2, 2026 · Novo Nordisk A S (NVO)
Key TakeawaysEli Lilly raised its 2026 revenue guidance to $91 billion to $92 billion, its second raise in three months, and Elon Musk backed CEO Dave Ricks on X a day later. Mounjaro and Zepbound made 65% of revenue in the first half of 2026, and everything else Lilly sells grew just $95 million in 2025.
Not investment advice. Headline and summary only, not a full reprint.